Joseph Sciasci, PharmD, BCPS, BCOP
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Pharmacy Practice (PGY 1) - Children’s Hospital of Wisconsin, Milwaukee, WI
Pharmacy Practice (PGY 2) - St. Jude Children’s Research Hospital, Memphis, TN
PharmD - Philadelphia College of Pharmacy at the University of the Sciences, Philadelphia, PA
Clinical Pharmacy Specialist
Implementation of pharmacogenetics into clinical practice
Discharge medication counseling
Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, Swanson HD, Wolf J, Greene W. 2018. Pentamidine for prophylaxis against Pneumocystis jirovecii pneumonia in pediatric oncology patients receiving immunosuppressive chemotherapy. Antimicrob Agents Chemother 62:e00173-18.
Hill DA, Leahy AB, Sciasci JN, O’Neill SP, Reilly A, Balamuth N, Seeholzer SH, Spergel JM, Brown-Whitehorn TF. Medication contaminants as a potential cause of anaphylaxis to vincristine. J Pediatr Blood Cancer. 2018 Jan;65(1).
Hill DA, Leahy AB, Sciasci J, et. al. Medication contaminants as a potential cause of anaphylaxis to vincristine. Pediatr Blood Cancer. 2017;00:e26761.
Watts CS, Sciasci JN, Pauley JL, Panetta JC, PeiDE, Cheng CH, Christensen CM, Mikkelsen TS, Pui CH, Jeha SI, Relling MV. Prophylactic trimethoprim-sulfamethoxazole does not affect pharmacokinetics or pharmacodynamics of methotrexate. J Pediatr Hematol Oncol 2016 Aug;38(6):449-52.
Pediatric Pharmacy Advocacy Group (PPAG)
Children’s Oncology Group (COG)
American Society of Health-System Pharmacy (ASHP)
American College of Clinical Pharmacy (ACCP)